Literature DB >> 24810368

Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models-a cohort study in 180 patients.

Sven F Garbade1, Cheryl R Greenberg, Mübeccel Demirkol, Gülden Gökçay, Antonia Ribes, Jaume Campistol, Alberto B Burlina, Peter Burgard, Stefan Kölker.   

Abstract

BACKGROUND: Glutaric aciduria type I (GA-I) is a cerebral organic aciduria caused by inherited deficiency of glutaryl-CoA dehydrogenase and is characterized biochemically by an accumulation of putatively neurotoxic dicarboxylic metabolites. The majority of untreated patients develops a complex movement disorder with predominant dystonia during age 3-36 months. Magnetic resonance imaging (MRI) studies have demonstrated striatal and extrastriatal abnormalities. AIMS/
METHODS: The major aim of this study was to elucidate the complex neuroradiological pattern of patients with GA-I and to associate the MRI findings with the severity of predominant neurological symptoms. In 180 patients, detailed information about the neurological presentation and brain region-specific MRI abnormalities were obtained via a standardized questionnaire.
RESULTS: Patients with a movement disorder had more often MRI abnormalities in putamen, caudate, cortex, ventricles and external CSF spaces than patients without or with minor neurological symptoms. Putaminal MRI changes and strongly dilated ventricles were identified as the most reliable predictors of a movement disorder. In contrast, abnormalities in globus pallidus were not clearly associated with a movement disorder. Caudate and putamen as well as cortex, ventricles and external CSF spaces clearly collocalized on a two-dimensional map demonstrating statistical similarity and suggesting the same underlying pathomechanism.
CONCLUSIONS: This study demonstrates that complex statistical methods are useful to decipher the age-dependent and region-specific MRI patterns of rare neurometabolic diseases and that these methods are helpful to elucidate the clinical relevance of specific MRI findings.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24810368     DOI: 10.1007/s10545-014-9676-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  34 in total

1.  Glutaric acidemia type 1: outcomes before and after expanded newborn screening.

Authors:  Krista Viau; Sharon L Ernst; Rena J Vanzo; Lorenzo D Botto; Marzia Pasquali; Nicola Longo
Journal:  Mol Genet Metab       Date:  2012-06-09       Impact factor: 4.797

2.  Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency.

Authors:  Stefan Kölker; Sven F Garbade; Cheryl R Greenberg; James V Leonard; Jean-Marie Saudubray; Antonia Ribes; H Serap Kalkanoglu; Allan M Lund; Begoña Merinero; Moacir Wajner; Mónica Troncoso; Monique Williams; John H Walter; Jaume Campistol; Milagros Martí-Herrero; Melissa Caswill; Alberto B Burlina; Florian Lagler; Esther M Maier; Bernd Schwahn; Aysegul Tokatli; Ali Dursun; Turgay Coskun; Ronald A Chalmers; David M Koeller; Johannes Zschocke; Ernst Christensen; Peter Burgard; Georg F Hoffmann
Journal:  Pediatr Res       Date:  2006-04-26       Impact factor: 3.756

3.  Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A.

Authors:  Sven W Sauer; Jürgen G Okun; Marina A Schwab; Linda R Crnic; Georg F Hoffmann; Stephen I Goodman; David M Koeller; Stefan Kölker
Journal:  J Biol Chem       Date:  2005-04-19       Impact factor: 5.157

Review 4.  Striatal degeneration and spongy myelinopathy in glutaric acidemia.

Authors:  D Soffer; N Amir; O N Elpeleg; J M Gomori; R S Shalev; S Gottschalk-Sabag
Journal:  J Neurol Sci       Date:  1992-02       Impact factor: 3.181

5.  Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort.

Authors:  Christopher B R Funk; Asuri N Prasad; Patrick Frosk; Sven Sauer; Stefan Kölker; Cheryl R Greenberg; Marc R Del Bigio
Journal:  Brain       Date:  2005-02-02       Impact factor: 13.501

6.  Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood-brain barrier and the choroid plexus.

Authors:  Sven W Sauer; Silvana Opp; Anne Mahringer; Marcin M Kamiński; Christian Thiel; Jürgen G Okun; Gert Fricker; Marina A Morath; Stefan Kölker
Journal:  Biochim Biophys Acta       Date:  2010-03-17

7.  Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome.

Authors:  Avihu Boneh; Miriam Beauchamp; Maureen Humphrey; Jemma Watkins; Heidi Peters; Joy Yaplito-Lee
Journal:  Mol Genet Metab       Date:  2008-04-14       Impact factor: 4.797

8.  Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I.

Authors:  Inga Harting; Eva Neumaier-Probst; Angelika Seitz; Esther M Maier; Birgit Assmann; Ivo Baric; Monica Troncoso; Chris Mühlhausen; Johannes Zschocke; Nikolas P S Boy; Georg F Hoffmann; Sven F Garbade; Stefan Kölker
Journal:  Brain       Date:  2009-05-11       Impact factor: 13.501

9.  Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany.

Authors:  Stefan Kölker; Sven F Garbade; Nikolas Boy; Esther M Maier; Thomas Meissner; Chris Mühlhausen; Julia B Hennermann; Thomas Lücke; Johannes Häberle; Jochen Baumkötter; Wolfram Haller; Edith Muller; Johannes Zschocke; Peter Burgard; Georg F Hoffmann
Journal:  Pediatr Res       Date:  2007-09       Impact factor: 3.756

10.  Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency.

Authors:  Kevin A Strauss; Patrick Donnelly; Max Wintermark
Journal:  Brain       Date:  2009-12-23       Impact factor: 13.501

View more
  14 in total

1.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.

Authors:  Stefan Kölker; Vassili Valayannopoulos; Alberto B Burlina; Jolanta Sykut-Cegielska; Frits A Wijburg; Elisa Leão Teles; Jiri Zeman; Carlo Dionisi-Vici; Ivo Barić; Daniela Karall; Jean-Baptiste Arnoux; Paula Avram; Matthias R Baumgartner; Javier Blasco-Alonso; S P Nikolas Boy; Marlene Bøgehus Rasmussen; Peter Burgard; Brigitte Chabrol; Anupam Chakrapani; Kimberly Chapman; Elisenda Cortès I Saladelafont; Maria L Couce; Linda de Meirleir; Dries Dobbelaere; Francesca Furlan; Florian Gleich; Maria Julieta González; Wanda Gradowska; Stephanie Grünewald; Tomas Honzik; Friederike Hörster; Hariklea Ioannou; Anil Jalan; Johannes Häberle; Gisela Haege; Eveline Langereis; Pascale de Lonlay; Diego Martinelli; Shirou Matsumoto; Chris Mühlhausen; Elaine Murphy; Hélène Ogier de Baulny; Carlos Ortez; Consuelo C Pedrón; Guillem Pintos-Morell; Luis Pena-Quintana; Danijela Petković Ramadža; Esmeralda Rodrigues; Sabine Scholl-Bürgi; Etienne Sokal; Marshall L Summar; Nicholas Thompson; Roshni Vara; Inmaculada Vives Pinera; John H Walter; Monique Williams; Allan M Lund; Angeles Garcia-Cazorla; Angeles Garcia Cazorla
Journal:  J Inherit Metab Dis       Date:  2015-04-15       Impact factor: 4.982

2.  Impact of age at onset and newborn screening on outcome in organic acidurias.

Authors:  Jana Heringer; Vassili Valayannopoulos; Allan M Lund; Frits A Wijburg; Peter Freisinger; Ivo Barić; Matthias R Baumgartner; Peter Burgard; Alberto B Burlina; Kimberly A Chapman; Elisenda Cortès I Saladelafont; Daniela Karall; Chris Mühlhausen; Victoria Riches; Manuel Schiff; Jolanta Sykut-Cegielska; John H Walter; Jiri Zeman; Brigitte Chabrol; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2015-12-21       Impact factor: 4.982

3.  Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders.

Authors:  Roland Posset; Angeles Garcia-Cazorla; Vassili Valayannopoulos; Elisa Leão Teles; Carlo Dionisi-Vici; Anaïs Brassier; Alberto B Burlina; Peter Burgard; Elisenda Cortès-Saladelafont; Dries Dobbelaere; Maria L Couce; Jolanta Sykut-Cegielska; Johannes Häberle; Allan M Lund; Anupam Chakrapani; Manuel Schiff; John H Walter; Jiri Zeman; Roshni Vara; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2016-04-22       Impact factor: 4.982

Review 4.  Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.

Authors:  Nikolas Boy; Chris Mühlhausen; Esther M Maier; Jana Heringer; Birgit Assmann; Peter Burgard; Marjorie Dixon; Sandra Fleissner; Cheryl R Greenberg; Inga Harting; Georg F Hoffmann; Daniela Karall; David M Koeller; Michael B Krawinkel; Jürgen G Okun; Thomas Opladen; Roland Posset; Katja Sahm; Johannes Zschocke; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2016-11-16       Impact factor: 4.982

5.  Induction of Neuroinflammatory Response and Histopathological Alterations Caused by Quinolinic Acid Administration in the Striatum of Glutaryl-CoA Dehydrogenase Deficient Mice.

Authors:  Alexandre Umpierrez Amaral; Bianca Seminotti; Janaína Camacho da Silva; Francine Hehn de Oliveira; Rafael Teixeira Ribeiro; Carmen Regla Vargas; Guilhian Leipnitz; Abel Santamaría; Diogo Onofre Souza; Moacir Wajner
Journal:  Neurotox Res       Date:  2017-12-12       Impact factor: 3.911

6.  Glutaric Acidemia Type 1: A Case of Infantile Stroke.

Authors:  Gül Demet Kaya Ozcora; Songul Gokay; Mehmet Canpolat; Fatih Kardaş; Mustafa Kendirci; Sefer Kumandaş
Journal:  JIMD Rep       Date:  2017-04-15

7.  Glutaric Acidemia Type 1-Clinico-Molecular Profile and Novel Mutations in GCDH Gene in Indian Patients.

Authors:  Neerja Gupta; Pawan Kumar Singh; Manoj Kumar; Shivaram Shastri; Sheffali Gulati; Atin Kumar; Anuja Agarwala; Seema Kapoor; Mohandas Nair; Savita Sapra; Sudhisha Dubey; Ankur Singh; Punit Kaur; Madhulika Kabra
Journal:  JIMD Rep       Date:  2015-03-12

8.  Occurrence of subdural hematomas in Dutch glutaric aciduria type 1 patients.

Authors:  Marloes E M Vester; Gepke Visser; Frits A Wijburg; Francjan J van Spronsen; Monique Williams; Rick R van Rijn
Journal:  Eur J Pediatr       Date:  2016-05-31       Impact factor: 3.183

Review 9.  Subdural hematomas: glutaric aciduria type 1 or abusive head trauma? A systematic review.

Authors:  Marloes E M Vester; Rob A C Bilo; Wouter A Karst; Joost G Daams; Wilma L J M Duijst; Rick R van Rijn
Journal:  Forensic Sci Med Pathol       Date:  2015-07-29       Impact factor: 2.007

10.  Glutaric aciduria type 1 as a cause of dystonic cerebral palsy.

Authors:  Sarar Mohamed; Muddathir H Hamad; Hamdy H Hassan; Mustafa A Salih
Journal:  Saudi Med J       Date:  2015-11       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.